Autres

Scale drug discovery with quantum-inspired physics and generative AI AQEMIA is a drug invention company dedicated to novel medicines — never me-toos — tackling major diseases such as oncology. Our physics-based, generative AI platform invents drug candidates beyond the reach of traditional R&D, without dependence on experimental data. We are … [voir plus]

BIOME9 is revolutionising pet care, through personalised, data-led solutions. We use cutting-edge science and AI to decode the complex science of the gut microbiome, eliminating the guesswork around choosing the right diet and nutrition for our dogs. If there was one thing you could do to transform your dog’s health … [voir plus]

GYANT’s empathic virtual assistant guides patients through the complexity of their digital healthcare journeys. We’re all patients, and we all know how difficult it is to navigate the complexity of healthcare—from education to access to transparency. GYANT eases patient confusion and frustration by virtually guiding them to their desired and … [voir plus]

Building the future of AI drug development with the data that matters. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and … [voir plus]

Restoring the human connection at the heart of healthcare through industry-leading clinical AI. Nabla powers smarter clinical workflows at the point of care, giving clinicians a fast and flexible experience built for real-world practice. Seamlessly integrated into any EHR, Nabla performs consistently across specialties and languages. Designed for the clinician … [voir plus]

Personal Health OS infrastructure behind the world’s leading health, wellness & longevity companies. ONVY powers the Personal Health OS infrastructure behind the next generation of health, wellness, nutrition and longevity companies. We unify wearables, labs, nutritional and lifestyle data into one intelligence layer - transforming fragmented health signals into contextual … [voir plus]

We create the first closed-loop AI generative biology company to create the new standard of biology reasoning Owkin is building the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation, while reshaping how humanity understands and engineers biology. Like other frontier AI companies, we believe the leap from narrow … [voir plus]

Pieces is now part of Smarter Technologies Pieces joined Smarter Technologies in 2025. The applied generative AI capabilities previously associated with Pieces are now part of Smarter Technologies, supporting clearer clinical insight, more informed decision-making, and better alignment across healthcare operations. To maintain clear and consistent communication, updates and insights … [voir plus]